BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 37989214)

  • 1. Leptomeningeal Carcinomatosis from Solid Tumor Malignancies: Treatment Strategies and Biomarkers.
    Malani R; Bhatia A; Warner AB; Yang JT
    Semin Neurol; 2023 Dec; 43(6):859-866. PubMed ID: 37989214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leptomeningeal metastasis from solid tumors.
    Thakkar JP; Kumthekar P; Dixit KS; Stupp R; Lukas RV
    J Neurol Sci; 2020 Apr; 411():116706. PubMed ID: 32007755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leptomeningeal Metastasis: A Review of the Pathophysiology, Diagnostic Methodology, and Therapeutic Landscape.
    Nguyen A; Nguyen A; Dada OT; Desai PD; Ricci JC; Godbole NB; Pierre K; Lucke-Wold B
    Curr Oncol; 2023 Jun; 30(6):5906-5931. PubMed ID: 37366925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leptomeningeal disease.
    Groves MD
    Neurosurg Clin N Am; 2011 Jan; 22(1):67-78, vii. PubMed ID: 21109151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathological and Treatment-Associated Prognostic Factors in Patients with Breast Cancer Leptomeningeal Metastases in Relation to Tumor Biology.
    Griguolo G; Pouderoux S; Dieci MV; Jacot W; Bourgier C; Miglietta F; Firmin N; Conte P; Viala M; Guarneri V; Darlix A
    Oncologist; 2018 Nov; 23(11):1289-1299. PubMed ID: 30120164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A systematic review of craniospinal irradiation for leptomeningeal disease: past, present, and future.
    Maillie L; Salgado LR; Lazarev S
    Clin Transl Oncol; 2021 Oct; 23(10):2109-2119. PubMed ID: 33881707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Newer avenues for the treatment of leptomeningeal carcinomatosis.
    Meriggi F; Zaniboni A
    Cent Nerv Syst Agents Med Chem; 2011 Mar; 11(1):38-44. PubMed ID: 21250935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leptomeningeal Metastases in Melanoma Patients: An Update on and Future Perspectives for Diagnosis and Treatment.
    Steininger J; Gellrich FF; Engellandt K; Meinhardt M; Westphal D; Beissert S; Meier F; Glitza Oliva IC
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel approaches to treating leptomeningeal metastases.
    Grewal J; Saria MG; Kesari S
    J Neurooncol; 2012 Jan; 106(2):225-34. PubMed ID: 21874597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case report of prostate cancer with leptomeningeal metastasis.
    Dehghani M; PeyroShabany B; Shahraini R; Fazilat-Panah D; Hashemi F; Welsh JS; Javadinia SA
    Cancer Rep (Hoboken); 2022 Aug; 5(8):e1463. PubMed ID: 34089302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leptomeningeal carcinomatosis. How does cancer reach the pia-arachnoid?
    Kokkoris CP
    Cancer; 1983 Jan; 51(1):154-60. PubMed ID: 6336971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leptomeningeal Carcinomatosis: Molecular Landscape, Current Management, and Emerging Therapies.
    Bhambhvani HP; Rodrigues AJ; Umeh-Garcia MC; Hayden Gephart M
    Neurosurg Clin N Am; 2020 Oct; 31(4):613-625. PubMed ID: 32921356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical trial of proton craniospinal irradiation for leptomeningeal metastases.
    Yang TJ; Wijetunga NA; Yamada J; Wolden S; Mehallow M; Goldman DA; Zhang Z; Young RJ; Kris MG; Yu HA; Seidman AD; Gavrilovic IT; Lin A; Santomasso B; Grommes C; Piotrowski AF; Schaff L; Stone JB; DeAngelis LM; Boire A; Pentsova E
    Neuro Oncol; 2021 Jan; 23(1):134-143. PubMed ID: 32592583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Craniospinal irradiation in the treatment of chemotherapy refractory leptomeningeal metastasis from breast cancer: A case report.
    Tesolin D; Vergidis D; Ramchandar K
    Cancer Rep (Hoboken); 2022 Jul; 5(7):e1556. PubMed ID: 34761557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrathecal chemotherapy.
    Kerr JZ; Berg S; Blaney SM
    Crit Rev Oncol Hematol; 2001 Mar; 37(3):227-36. PubMed ID: 11248578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacotherapy for leptomeningeal disease in breast cancer.
    Bartsch R; Jerzak KJ; Larrouquere L; Müller V; Le Rhun E
    Cancer Treat Rev; 2024 Jan; 122():102653. PubMed ID: 38118373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leptomeningeal metastases: rationale for systemic chemotherapy or what is the role of intra-CSF-chemotherapy?
    Siegal T
    J Neurooncol; 1998; 38(2-3):151-7. PubMed ID: 9696366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Most common sites on MRI of intracranial neoplastic leptomeningeal disease.
    Debnam JM; Mayer RR; Chi TL; Ketonen L; Weinberg JS; Wei W; Groves MD; Guha-Thakurta N
    J Clin Neurosci; 2017 Nov; 45():252-256. PubMed ID: 28802798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leveraging Molecular and Immune-Based Therapies in Leptomeningeal Metastases.
    Wilcox JA; Boire AA
    CNS Drugs; 2023 Jan; 37(1):45-67. PubMed ID: 36474108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leptomeningeal carcinomatosis in patients with breast cancer.
    Franzoi MA; Hortobagyi GN
    Crit Rev Oncol Hematol; 2019 Mar; 135():85-94. PubMed ID: 30819451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.